Description
Sitagliptin Phosphate Tablets are clinically approved for managing blood sugar levels in individuals with type 2 diabetes.
- Key Features: Efficacy: Proven to significantly reduce Hb A1c levels, contributing toenhanced glycemic control.
- Mechanism: Functions as a DPP-4 inhibitor, increasing incretin levels, thus stimulating the release of insulin and decreasing glucagon levels in circulation.
- Usability: Easy-to-administer oral tablets, taken once daily, ensuringsimplicity and adherence to treatment.
- Compatibility: Can be used alone or in combination with otherantidiabetic medications.
- Safety: Established safety profile when used under physician guidancewith minimal risk of adverse effects.
